Korman Tyler Paz's Form 4 filing
Exozymes Inc. (EXOZ) · filed Apr 10, 2026
- Accession no.
- 0001493152-26-016166
- Filed
- Apr 10, 2026
- Trade date
- Apr 8-9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $15.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Korman Tyler PazCIK 0002032745 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | COMMON STOCK | SSaleDisposed | −750 | $10.04 | −$7,530 | 729,873 | Direct | |
| Apr 9, 2026 | COMMON STOCK | SSaleDisposed | −750 | $10.53 | −$7,897.5 | 729,123 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.